Recent Articles
ONK Therapeutics Closes New Financing and Appoints Chris Nowers as CEO
GALWAY, Ireland--(BUSINESS WIRE)--ONK Therapeutics Ltd, an innovative natural killer (NK) cell therapy company, today announced that it has raised US$8M in a financing from...
Transgene: Acceptance of Late Breaking Abstract at Upcoming SITC 2020 Conference, on The Detailed Results From Clinical Study of TG4001 in Combination With Avelumab...
STRASBOURG, France--(BUSINESS WIRE)--Regulatory News:
Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, announced that detailed results of...
Akron Biotech Signs Agreement With Synairgen plc to Supply Interferon-beta for COVID-19 Treatment
BOCA RATON, Fla.--(BUSINESS WIRE)--Akron Biotechnology today announced it has signed an agreement with Synairgen plc (LSE: SNG) for the provision of SNG001, Synairgen’s wholly-owned...
Ultimovacs Announces Updated Positive Results from Phase I Trial Evaluating Universal Cancer Vaccine, UV1, in Non-Small Cell Lung Cancer
OSLO, Norway--(BUSINESS WIRE)--Ultimovacs ASA ("Ultimovacs", ticker ULTIMO), today announced five-year overall survival data from the Phase I trial evaluating UV1 as maintenance therapy in...
Genesis Therapeutics Enters AI-driven, Multi-Target Drug Discovery Partnership with Genentech
BURLINGAME, Calif.--(BUSINESS WIRE)--Genesis Therapeutics, a privately-held company inventing and deploying state-of-the-art artificial intelligence (AI) techniques to augment drug discovery and development, today announced that...
AVEO Oncology Announces Appointment of David W. Crist as Vice President of Sales
BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced the appointment of David Crist as Vice President of Sales. In this role, Mr. Crist will be...
Nimbus Therapeutics Appoints Erin Cowhig as Chief People Officer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, today announced the appointment of Erin Cowhig as...
SG Blocks and OSANG Healthcare Announce Managed Supply Agreement and Purchase Order to Distribute COVID-19 Rapid Test
NEW YORK--(BUSINESS WIRE)--SG Blocks, Inc. (Nasdaq: SGBX) ("SG Blocks" or the "Company"), a leader in modular container-based structures and innovator in portable, clinical-grade laboratories...
Prestige Biopharma Receives Positive EMA Opinion on Orphan Designation for PBP1510 for Treatment of Pancreatic Cancer
SINGAPORE--(BUSINESS WIRE)--Prestige BioPharma Ltd. (hereinafter “Prestige BioPharma”) today announced that the European Medicines Agency (EMA) Orphan Drug Commission (COMP) has granted a positive opinion...
Octapharma announces FDA approval of updated NUWIQ® Prescribing Information to include immunogenicity data in previously untreated patients
LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved an updated Prescribing Information (PI) for NUWIQ®,...
Veracyte Announces New Data Reinforcing Foundational Technology of Nasal Swab Test for Early Lung Cancer Detection Presented at CHEST Annual Meeting 2020
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc., (Nasdaq: VCYT) today announced that new data presented at the CHEST Annual Meeting 2020 show that a genomic...
Inflection Biosciences Announces Appointment of Gregory I. Berk, MD, to its Board of Directors
DUBLIN--(BUSINESS WIRE)--Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer, today announced the appointment of industry veteran Gregory I. Berk,...
Comparative Analysis of COVID-19 Reveals a Cytokine Shower, Not a Storm
MANHASSET, N.Y.--(BUSINESS WIRE)--Since coronavirus disease 2019 (COVID-19) emerged, researchers and doctors have suggested that the infection provokes a destructive immune response known as a...
Eurofins U.S. Clinical Diagnostics Network Receives EUA Approval of At Home COVID-19 Test
LUXEMBOURG--(BUSINESS WIRE)--Eurofins U.S. Clinical Diagnostics, announced that Clinical Enterprise Inc. has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration...
Versantis Receives FDA Rare Pediatric Disease Designation for VS-01 for the Treatment of Urea Cycle Disorders
ZURICH, Switzerland--(BUSINESS WIRE)--Versantis AG, a clinical-stage company developing novel therapies for orphan liver diseases, today announced that the U.S. Food and Drug Administration (FDA)...